Filter News

Recent News

7 September 2020

Back British biotech by improving the clinical trials process

Andrew Boyle, CEO of LGB & Co. Limited, wrote an article for Pharmiweb on how to improve the British biotech sector. Read more
1 September 2020

Is it safe to get back in the water? SME credit investments in the post-Covid world

Please join us to hear from our expert panel on how investors are viewing the market and assessing SME risk and resilience over the next 6 months and beyond. Read more
27 August 2020

COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts

Andrew Boyle, CEO of LGB & Co. Limited, wrote an article published in PharmaPhorum on the impact COVID-19 is having on the biotech sector in the UK. Read more
27 July 2020

Scancell Raises £15m to Progress Three Clinical Programmes

On 22 July, Scancell announced a transformational £15 million fundraising that will enable the company to progress its three clinical programmes. Read more
17 July 2020

City gears up for rush of corporate takeovers sparked by Covid

Ivan Sedgwick, Investment Director, contributed to an article in the Evening Standard on a potential rush of corporate takeovers. Read more
15 July 2020

Debate: With the economy under such strain, should new fintech regulation be paused?

Andrew Boyle, CEO of LGB & Co. Limited, participated in a debate with Elisabeth Kohlbach, co-founder and chief executive at Skwire, on fintech regulations and whether they should be paused. Read more
3 July 2020

LGB joint bookrunner in £30m equity placing for AFC Energy

LGB & Co. Limited has acted as a Joint Bookrunner for AFC Energy plc (AIM: AFC), a leading provider of hydrogen power generation technologies on a £30 million equity placing.  Read more
30 June 2020

How to get your business out from under the COVID-19 debt mountain

Growth businesses face owing £105bn in debt because of COVID-19. Angus Grierson, Managing Director of LGB Corporate Finance, shows the various ways you can escape the debt mountain.   Read more
22 June 2020

Caveat AIMptor - buyer beware

Ivan Sedgwick, Investments Director at LGB & Co. Limited, contributed to an article for ProActive Investors on the AIM market for investors. Read more
26 May 2020

BoE: Negative interest rates not ruled out

Andrew Boyle, CEO of LGB & Co. Limited, contributed to an article for Mortgage Introducer Bank of England Governor Andrew Bailey's refusal to rule out the prospect of negative interest rates.   Read more
4 May 2020

Small cap movers: Coronavirus crisis shines a light on small-cap pharma

Ivan Sedgwick, Investments Director at LGB & Co. Limited, contributed to an article for ProActive Investors on small-cap pharmaceutical companies in the Coronavirus limelight. Read more
30 April 2020

What impact is COVID-19 having on stocks?

Ivan Sedgwick, Director of Investments at LGB & Co, spoke to BLM to find out about the current outlook for the AIM market.   Read more